MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Turning during single and dual tasking in Parkinson’s Disease

    E. Bianchini, E. Warmerdam, R. Romijnders, J. Hoffmann, G. Schmidt, F. Pontieri, C. Hansen, W. Maetzler (Rome, Italy)

    Objective: To investigate turning kinematics and intersegmental coordination in single (ST) and dual tasking (DT) in Parkinson’s Disease (PD) patients. Background: Successful turning depends on…
  • 2022 International Congress

    Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

    B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the form Background: Neurotrophic factors…
  • 2022 International Congress

    Validation of the PD Home Diary for Assessment of Motor Fluctuations in Advanced Parkinson’s Disease

    M. Löhle, A. Bremer, F. Gandor, J. Timpka, P. Odin, G. Ebersbach, A. Storch (Rostock, Germany)

    Objective: To determine the validity of the Parkinson’s disease (PD) home diary for quantification of motor states in patients with advanced PD and motor fluctuations.…
  • 2022 International Congress

    VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE

    L. Simón, E. Cubo, J. Rivadeneyra, C. Collazo, M. Soto, J. Raya, D. Castillo, S. Calvo, A. Fernández (Burgos, Spain)

    Objective: to validate the use of accelerometers to quantify energy expenditure (EE) under controlled conditions for Huntington’s disease (HD) patients using Indirect Calorimetry (IC) as…
  • 2022 International Congress

    Levodopa–entacapone–carbidopa intestinal gel infusion for advanced Parkinson’s disease patients – data from a Romanian center

    A. Dulamea, T. Barbulescu, C. Banica (Bucharest, Romania)

    Objective: To report the experience with levodopa–entacapone–carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease (PD) from a Romanian center. Background: LECIG…
  • 2022 International Congress

    The role of intraoperative electrophysiological monitoring in implanting globus pallidus internus electrodes in patients with dystonia

    J. Kunst, D. Hrabovsky, T. Jurkova, J. Chrastina, M. Balaz (Brno, Czech Republic)

    Objective: The first aim was to compare the preplanned GPi electrode neuroradiological trajectory with the final trajectory selected after electrophysiological monitoring. The second aim was…
  • 2022 International Congress

    Affected tongue movements in idiopathic REM sleep behavior disorder

    T. Thies, N. Geerts, D. Mücke, A. Seger, M. Barbe, M. Sommerauer (Cologne, Germany)

    Objective: In Parkinson’s disease (PD), recognition of speech deviations often follows clinical diagnosis. But what if speech is a prodromal biomarker in PD? The study…
  • 2022 International Congress

    A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

    N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

    Objective: To investigate the feasibility and efficacy of online-based Cognitive Behavioral Therapy (CBT) for anxiety in Parkinson's disease (PD). Background: Anxiety symptoms in Parkinson's disease…
  • 2022 International Congress

    TREMOR AND BRADYKINESIA ARE TWO UNRELATED SIDE EFFECTS INDUCED BY VALPROATE INTAKE

    A. de Biase, G. Paparella, L. Angelini, A. Cannavacciuolo, D. Colella, E. Cerulli Irelli, A. Gialllonardo, C. Di Bonaventura, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: To better characterize clinical and neurophysiological features of valproate-induced tremor in patients with epilepsy and the effect of valproate on the execution of voluntary…
  • 2022 International Congress

    Two cases of myoclonic ataxia with and without epilepsy associated with NUS1

    G. Riboldi, E. Monfrini, C. Miller, A. Di Fonzo, S. Frucht (New York, USA)

    Objective: To describe two cases of myoclonic ataxia due to two novel NUS1 pathogenic variants Background: The genetic bases of myoclonus is not well defined. Myoclonus is…
  • « Previous Page
  • 1
  • …
  • 784
  • 785
  • 786
  • 787
  • 788
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley